TAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Market capitalization
‪6.52 T‬JPY
‪317.02 B‬JPY
‪4.03 T‬JPY
‪1.51 B‬
Beta (1Y)
0.77

About TAKEDA PHARMACEUTICAL CO LTD

CEO
Christophe Weber
Headquarters
Osaka
Employees (FY)
‪49.1 K‬
Founded
1781
ISIN
JP3463000004
FIGI
BBG000BJPSD2
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4502 is 4300.00 JPY — it has decreased by 1.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SAPSE exchange TAKEDA PHARMACEUTICAL CO LTD stocks are traded under the ticker 4502.
TAKEDA PHARMACEUTICAL CO LTD is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for TAKEDA PHARMACEUTICAL CO LTD has a max estimate of 6054.20 JPY and a min estimate of 4200.00 JPY.
4502 earnings for the last quarter are −31.00 JPY whereas the estimation was 27.92 JPY which accounts for −211.01% surprise. Estimated earnings for the next quarter are 28.84 JPY. See more details about TAKEDA PHARMACEUTICAL CO LTD earnings.
TAKEDA PHARMACEUTICAL CO LTD revenue for the last quarter amounts to ‪1.04 T‬ JPY despite the estimated figure of ‪993.48 B‬ JPY. In the next quarter revenue is expected to reach ‪1.00 T‬ JPY.
Yes, you can track TAKEDA PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4502 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAKEDA PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
4502 reached its all-time high on Jan 10, 2018 with the price of 6550.00 JPY, and its all-time low was 2950.00 JPY and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪49.10 K‬ employees. See our rating of the largest employees — is TAKEDA PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAKEDA PHARMACEUTICAL CO LTD EBITDA is ‪1.22 T‬ JPY, and current EBITDA margin is 32.84%. See more stats in TAKEDA PHARMACEUTICAL CO LTD financial statements.